40
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Real-world experience of everolimus as second-line treatment in metastatic renal cell cancer after failure of pazopanib

, , , , , , , , & show all
Pages 4885-4893 | Published online: 06 Oct 2017

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.